Aura Biosciences (AURA) Other Accumulated Expenses (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Other Accumulated Expenses data on file, last reported at $378000.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 88.73% year-over-year to $378000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $378000.0 (down 88.73% YoY) and the FY2025 annual result came in at $242000.0, up 28.72% from the prior year.
• Other Accumulated Expenses advanced to $378000.0 in Q1 2026, from $242000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $7.1 million in Q3 2025 to a low of $188000.0 in Q4 2024.
• A 5-year average of $2.1 million and a median of $1.6 million in 2022 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses soared 960.0% — and 2024, when it sank 94.54%.
• Tracing AURA's Other Accumulated Expenses over 5 years: stood at $325000.0 in 2022, then soared by 960.0% to $3.4 million in 2023, then slumped by 94.54% to $188000.0 in 2024, then advanced by 28.72% to $242000.0 in 2025, then jumped by 56.2% to $378000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $378000.0 (Q1 2026), $242000.0 (Q4 2025), and $7.1 million (Q3 2025), per Business Quant data.